Literature DB >> 23386058

Vascular endothelial growth factor induces growth of uterine cervix and immune cell recruitment in mice.

Siobhan M Donnelly1, Bao Tran Nguyen, Scott Rhyne, Jordan Estes, Subrina Jesmin, Chishimba Nathan Mowa.   

Abstract

Knowledge of uterine cervical epithelial biology and factors that influence its events may be critical in understanding the process of cervical remodeling (CR). Here, we examine the impact of exogenous vascular endothelial growth factor (VEGF) on uterine cervical epithelial growth in mice (nonpregnant and pregnant) treated with VEGF agents (recombinant and inhibitor) using a variety of morphological and molecular techniques. Exogenous VEGF altered various uterine cervical epithelial cellular events, including marked induction of growth, edema, increase in inter-epithelial paracellular space, and recruitment of immune cells to the outer surface of epithelial cells (cervical lumen). We conclude that VEGF induces multiple alterations in the uterine cervical epithelial tissues that may play a role in local immune surveillance and uterine cervical growth during CR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23386058     DOI: 10.1530/JOE-12-0469

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  3 in total

1.  Transcriptomic profile of VEGF-regulated genes in human cervical epithelia.

Authors:  MacKinsey Johnson; Chishimba Nathan Mowa
Journal:  Cell Tissue Res       Date:  2021-01-29       Impact factor: 5.249

Review 2.  Immunity in the Cervix: Interphase between Immune and Cervical Epithelial Cells.

Authors:  Jorgelina Barrios De Tomasi; Michael Makokha Opata; Chishimba Nathan Mowa
Journal:  J Immunol Res       Date:  2019-04-17       Impact factor: 4.818

3.  CCR3 antagonist impairs estradiol-induced eosinophil migration to the uterus in ovariectomized mice.

Authors:  J M D Araújo; L A S Silva; F B Felix; E A Camargo; R Grespan
Journal:  Braz J Med Biol Res       Date:  2019-12-20       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.